FDA Inspection 1136171 — Northwest Arkansas Clinical Trials Center
The FDA completed an inspection of Northwest Arkansas Clinical Trials Center on February 10, 2021 in Rogers, AR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 10, 2021
- Fiscal Year
- 2021
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Rogers, AR (United States)
Additional Details
Clinical BA/BE